Adjuvant Zoledronic Acid Reduces Fractures in Breast Cancer Patients; An AZURE (BIG 01/04) Study

European Journal of Cancer - United Kingdom
doi 10.1016/j.ejca.2018.02.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Breast-Cancer Adjuvant Therapy With Zoledronic Acid

New England Journal of Medicine
Medicine
2012English

Innegligible Musculoskeletal Disorders Caused by Zoledronic Acid in Adjuvant Breast Cancer Treatment: A Meta-Analysis

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2011English

Zoledronic Acid Inhibits Macrophage/Microglia-Assisted Breast Cancer Cell Invasion

Oncotarget
Oncology
2013English

Study on Zoledronic Acid Reducing Acute Bone Loss and Fracture Rates in Elderly Postoperative Patients With Intertrochanteric Fractures

Orthopaedic surgery
SurgeryOrthopedicsSports Medicine
2019English

PCN67 Cost Effectiveness of Zoledronic Acid (ZOL) in Postmenopausal Women With Early Breast Cancer Receiving Adjuvant Letrozole From German and Italian Perspectives

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Metformin as an Adjuvant in Breast Cancer Treatment

SAGE Open Medicine
Medicine
2019English

Progress in Adjuvant Chemotherapy for Breast Cancer: An Overview

BMC Medicine
Medicine
2015English

Cost-Effectiveness of Regular Utilization of Zoledronic Acid for Developed Bone Metastases From Advanced Breast Cancer in Chinese Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Fracture Risk and Adjuvant Therapies in Young Breast Cancer Patients: A Population-Based Study

PLoS ONE
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy